Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

By Kalmadi Sujith   McNeill Giles   Davis Mellar   Peereboom David   Adelstein David   Mekhail Tarek  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 507-513

Humana Press, Inc

Access to resources Recommend Favorite

ERCC1 protein as a guide for individualized therapy of late-stage advanced non-small cell lung cancer

By                        

Experimental and Therapeutic Medicine, Vol. 2, Iss. 5, 2011-01 ,pp. : 811-815

Spandidos Publications

Access to resources Recommend Favorite

Molecular-targeted therapy for elderly patients with advanced non-small cell lung cancer (Review)

By                  

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 3-8

Spandidos Publications

Access to resources Recommend Favorite

Phase II study of liarozole in advanced non-small cell lung cancer

By O'Byrne K.J.   Han C.   Mitchell K.   Lane D.   Carmichael J.   Harris A.L.   Talbot D.C.  

European Journal of Cancer, Vol. 34, Iss. 9, 1998-08 ,pp. : 1463-1466

Elsevier

Access to resources Recommend Favorite

Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer

By Baron F.   Cueva J.   Grana B.   Curiel T.   Leon L.   Vazquez F.   Candamio S.   Lopez R.  

European Journal of Cancer, Vol. 37, Iss. 11, 2001-07 ,pp. : 1381-1384

Elsevier

Access to resources Recommend Favorite